Brain Access Sheath Safely Displace Subcortical Tissue

Placed through a small craniotomy, the BrainPath is advanced through the natural folds of the brain, using a parallel approach to the brain fiber tracts, thus reducing the potential for tissue damage that may cause deficits after surgery. The device consists of a reusable, resterilizable obturator and a disposable sheath. Once these two components are assembled they are held together by an interference (friction) fit.

After the creation of an appropriate craniotomy and dural incision, the BrainPath assembly is inserted into tissue to desired location, using depth bands on obturator and sheath as a reference during placement. Once in place, the sheath is advanced into position and the obturator removed. The sheath remains in the brain to serve as a protective portal that maintains access to the surgical site during tissue removal or fluid evacuation. The BrainPath device is a product of NICO (Indianapolis, IN, USA), and has been approved by the US Food and Drug Administration (FDA).

“Almost every day, we are seeing our designated BrainPath Center hospitals from around the country getting media attention because of the results they are seeing with patients who have had surgery with BrainPath,” said Jim Pearson, president and CEO of NICO Corporation. “These patients are amazed and elated with their postoperative results, but more than anything, they are asking why this procedure is not the new standard of care in neurosurgery.”

Related Links:
NICO